CIK 0000818033
- Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 942875566
- Phone
- +1 858-251-4400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- 4 Other acquisition CFO & SVP, Finance acquired 536 shares (other)
- 4 Open-market sale Executive VP, Drug Development sold 21,542 shares at $15.33 ($330,263)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 10,000 shares at $12.20 ($122,000)
- 4 Open-market buy Director bought 2,459,016 shares at $12.20 ($29,999,995)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other acquisition VP, Finance & CFO acquired 1,115 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President & CCO sold 100,000 shares at an average $23.30 ($2,329,895)
- 4 Exercise or conversion Chief Executive Officer acquired 4,630 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 15 of 30 · 585 filings